Scientists have engineered immune cells to be more effective at fighting T-cell leukemia. They modified these cells to lack a protein called CD147, which altered their behavior and showed...
CD99, which is highly expressed in T-acute lymphoblastic leukemia (T-ALL), could be an effective target for antibody-based treatment. In this study, researchers used a monoclonal antibody against CD99 called...
Scientists have created a modified version of an antibody that can precisely target a protein involved in cancer growth and spread. The original antibody was derived from a mouse,...